[deanclatworthy]

I’ve heard about these MCA treatments in articles but am surprised to hear in these comments about it actually already being in use.

My father is an immunocompromised transplant patient and has been isolating now since the start of the pandemic. His first two vaccines had no antibody response and we will get results on his third dose in just over a month from now.

The situation has been really difficult for us as a family and he’s not had human contact this whole time (lives alone, I’m in another country). His renal consultant and local NHS consultants offer no hope or mention of MCA treatment. Has anyone more information on this in the UK?

[JonathanFly]

A quick google search suggests they should be available now. The article specifically talks about the situation your father is in:

https://www.pharmatimes.com/news/nhs_patients_gain_access_to....

>Initially, Ronapreve will be targeted at hospitalised patients who have not mounted an antibody response against COVID-19.

>This includes individuals who are immunocompromised, such as patients with certain cancer or autoimmune diseases.

[deanclatworthy]

Thanks for the reply Jonathan. Sadly just for those who it's probably too late for, and a reactive response rather than pro-active (i.e. to prevent being hospitalised in the first place, given the amount of damage getting to that point can cause to an immunocompromised patient's body in the long term).